查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1986687

快速检测市场规模、份额和趋势分析报告：按产品、技术、应用、最终用途、地区和细分市场划分，预测期为 2026 年至 2033 年

Rapid Tests Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables), By Technology (Immunoassay, Molecular Diagnostics), By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10个工作天内

价格

快速检测市场概述

全球快速检测市场预计到 2025 年将达到 16.9 亿美元，预计到 2033 年将达到 32.5 亿美元，2026 年至 2033 年的复合年增长率为 8.30%。

人们认为，这种增长是由于老年人口增加、目标疾病负担加重以及自我检测和照护现场产品的使用日益普及所致。

上呼吸道感染疾病（URI）在世界范围内极为常见，最近的全球估计显示，其发病率超过每 10 万人 162,000 例，这凸显了在临床环境中快速区分病毒和细菌病因的必要性。

2025年，上呼吸道感染疾病（URTI）仍然是全球主要的健康问题之一，5岁以下儿童和患有潜在疾病的成年人的发生率尤其高。 5岁以下儿童是上呼吸道感染最易感族群，97%的儿童呼吸道合胞病毒（RSV）相关死亡病例发生在低收入和中等收入国家。

此外，呼吸道融合细胞病毒（RSV）是一种高发生病毒感染疾病，尤其容易感染婴幼儿和老年人。据估计，全球每年约有3,300万感染疾病由RSV引起，其中超过300万例需要住院治疗。在美国，RSV每年导致5岁以下儿童5.8万至8万例住院病例和100至300例死亡病例，以及65岁及以上成人6万至16万例住院病例和6000至1万例死亡病例。 RSV的季节性爆发通常发生在秋冬季，对医疗系统造成重大影响，凸显了有效诊断和预防措施的迫切需求。

以下是截至 2025 年 1 月 7 日，北半球各国向 FluNet 报告的 2017 年 10 月 1 日至 2024 年 12 月 30 日期间按亚型分類的病毒检测数量比较：

此资料集显示了全球范围内进行的快速诊断测试的估计数量，与观察到的呼吸道病原体活动相对应：

由于流感季节性高发生且快速免疫诊断测试（RIDT）广泛普及，快速流感检测的需求在所有呼吸道检测中占比最大。这将推动快速流感诊断测试市场在预测期内实现高速成长。

由于需要对儿童和高风险族群进行筛检，对快速呼吸道合胞病毒 (RSV) 检测的需求显着增加。

hMPV 占据了虽小但​​重要的市场份额，尤其是在专门针对 hMPV 的多重检测平台中。

这些因素共同表明，呼吸道疾病的季节性趋势如何反映在诊断需求中，突显了季节性和病原体特异性检测的使用，这构成了市场扩张的基础。

快速检测在感染疾病监测和整体发挥日益重要的策略作用。到2025年，世界各国政府和卫生部门正在扩大快速诊断试剂盒的覆盖范围，以应对除新冠肺炎以外的其他地方性疾病。例如，印度医学研究理事会（ICMR）正在倡导在基层医疗中心提供乙型肝炎、镰状贫血和梅毒等疾病的快速检测，旨在改善服务不足地区的早期诊断。同时，随着季节性流感和呼吸道疾病在全球持续蔓延，某些快速检测（例如快速流感诊断试剂盒（RIDT））的市场预计将稳定成长。目标疾病范围的扩大意味着快速诊断的应用范围正在从上呼吸道感染疾病和败血症的筛检扩展到感染疾病和非传染性疾病。

创新和竞争格局正在重塑竞争格局和产品开发轨迹。各公司正日益整合人工智慧、机器学习和微流体等先进技术，以提高检测灵敏度、实现多参数同步测量并简化操作，从而加速其在临床和家庭环境中的应用。现有诊断公司和新参与企业也在影响市场的成长路径。例如，亚马逊计划于2025年中期进军印度主要城市，提供家庭诊断服务，这显着改变了投资者对诊断行业的信心。同时，诸如雅培计划收购Exact Sciences（一家广泛使用的癌症和基因检测製造商）等大规模战略倡议表明，诊断公司正在将其业务从传统的快速感染疾病检测扩展到更广泛的筛检产品线，同时在竞争日益激烈的市场中平衡品质保证和监管方面的挑战。

此外，罗氏诊断的「cobas infinity point-of-care」等行动应用程式的推出，将满足POC协调员的需求，并使他们能够随时随地透过智慧型手机完成任务，从而提高工作效率，预计这将在预测期内加速POC分子诊断产品的普及。

近年来，主要企业纷纷致力于将家用自测产品商业化，新冠疫情进一步加速了这个趋势。在政府实施封锁措施期间，这些产品既满足了临床需求，也促进了居家隔离。例如，雅培公司销售的「BinaxNOW Card」快速检测套组可用于检测流感和新冠病毒，15分钟内即可在家中取得检测结果。该产品配有虚拟指南和应用程序，方便用户完成检测流程并查看结果。

目录

第一章：调查方法和范围

第二章执行摘要

第三章 市场变数、趋势与范围

  • 市场历史及展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场趋势与展望
  • 市场动态
  • 商业环境分析
    • PESTLE分析
    • 波特五力分析
  • 新冠疫情影响分析

第四章 技术业务分析

  • 快速检测市场：基于技术的波动分析，2025-2033年
  • 分子诊断
  • 免疫检测
  • 其他的

第五章：依产品进行业务分析

  • 快速检测市场：产品特定波动分析，2025-2033年
  • 装置
  • 消耗品
  • 其他的

第六章 应用业务分析

  • 快速检测市场：基于应用领域的波动分析，2025-2033年
  • 上呼吸道感染疾病
    • 流感病毒/副流感病毒
    • 呼吸道融合细胞病毒
    • 链球菌
  • 抗药性感染疾病（例如抗甲氧西林金黄色葡萄球菌、链球菌等）
  • 败血症
    • 细菌性败血症
    • 霉菌性败血症
    • 其他的

第七章 依最终用途进行业务分析

  • 快速检测市场：依最终用途分類的波动分析，2025-2033年
  • 医院和诊所
  • 检查室
  • 家庭检测和其他

第八章：按地区分類的业务分析

  • 区域市场概览
  • 北美洲
    • 2021-2033年北美快速检测市场
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2021-2033年欧洲快速检测市场
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太地区快速检测市场，2021-2033年
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 2021-2033年拉丁美洲快速检测市场
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 2021-2033年中东和非洲快速检测市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争情势

  • 公司分类
  • 策略蓝图
    • 获得
    • 合伙
    • 新平台推出
    • 其他的
  • 公司简介/上市资讯
    • BD（Becton, Dickinson and Company）
    • Diasorin SPA
    • Abbott
    • Danaher Corporation
    • Thermo Fisher Scientific Inc
    • Biomerieux SA
    • F. Hoffmann-La Roche Ltd.
Product Code: GVR-4-68040-028-8

Rapid Tests Market Summary

The global rapid tests market size was estimated at USD 1.69 billion in 2025 and is projected to reach USD 3.25 billion by 2033, growing at a CAGR of 8.30% from 2026 to 2033. The growth can be attributed to the growing geriatric population, rising target disease burden, and increasing adoption of self-testing & point-of-care products.

Upper respiratory tract infections (URIs) remain extremely common worldwide, with incidence rates exceeding 162,000 per 100,000 people in recent global estimates, underscoring the need for rapid differentiation of viral versus bacterial causes in clinical practice.

Upper respiratory tract infections (URTIs) remain a major global health concern in 2025, with high incidence rates particularly in children under 5 and adults with underlying conditions. Children under 5 are the most affected group for URTIs, while 97% of pediatric RSV deaths occur in low- and middle-income countries.

Furthermore, Respiratory syncytial virus (RSV) is a highly prevalent viral infection that particularly affects infants, young children, and older adults. Globally, RSV is estimated to cause approximately 33 million acute lower respiratory tract infections annually in children under five years, with over 3 million cases requiring hospitalization. In the U.S., RSV leads to 58,000-80,000 hospitalizations and 100-300 deaths among children under five each year, as well as 60,000-160,000 hospitalizations and 6,000-10,000 deaths among adults aged 65 and older. Seasonal outbreaks typically occur in the fall and winter, significantly impacting healthcare systems and underscoring the critical need for effective diagnostic and preventive measures.

Below is a comparison of Virus detections by subtype reported to FluNet, 01 October 2017 to 30 December 2024, from countries in the Northern hemisphere, as of 07 January 2025:

The dataset plots estimated global volumes of rapid diagnostics that correspond with observed respiratory pathogen activity:

Influenza rapid test demand accounts for the largest share of total respiratory testing due to its high seasonal prevalence and broad availability of RIDTs. This results in high growth of the rapid influenza diagnostic tests market over the forecast years.

RSV rapid test demand is significant and growing, driven by pediatric and high-risk population screening.

hMPV contributes a smaller but meaningful share, especially where multiplex testing platforms incorporate hMPV targets.

Collectively, these drivers reflect how seasonal respiratory trends translate into diagnostic demand, highlighting the seasonality and pathogen-specific test utilization that underpins market expansion.

Across infectious disease surveillance and public health programs, rapid tests are increasingly playing a strategic role. Governments and health authorities in 2025 are scaling up access to rapid diagnostic kits for endemic conditions beyond COVID-19; for example, the Indian Council of Medical Research (ICMR) has advocated rapid test availability for conditions such as Hepatitis B, sickle cell anemia, and syphilis at primary health centres, aiming to improve early diagnosis in underserved areas. Meanwhile, markets for specific rapid tests, such as rapid influenza diagnostic tests (RIDTs), are projected to grow steadily as seasonal flu and respiratory illnesses persist globally. This widening scope of disease targets is expanding the application base of rapid diagnostics beyond upper respiratory infections and sepsis screening into the arenas of infectious and non-communicable diseases.

Innovation and competitive dynamics are reshaping the competitive landscape and product development trajectory. Providers are increasingly integrating advanced technologies such as AI, machine learning, and microfluidics to enhance test sensitivity, multiplexing, and ease of use, which supports broader adoption in both clinical and at-home settings. Established diagnostic players and new entrants are also influencing market growth paths: for instance, Amazon's entry into home diagnostics services across major Indian cities in mid-2025 triggered notable shifts in investor sentiment in the diagnostics sector. At the same time, large strategic moves like Abbott's planned acquisition of Exact Sciences-makers of widely used cancer and genetic tests signal diagnostic companies' push to diversify beyond traditional rapid infectious disease testing into broader screening portfolios, even as they balance quality assurance and regulatory challenges in an increasingly crowded market.

Furthermore, the introduction of mobile applications, such as cobas infinity point-of-care from Roche Diagnostics, to satisfy the requirements of the POC coordinator and aid in enhancing productivity by completing the task on the smartphone irrespective of the destination, can be expected to drive the adoption of POC molecular diagnostic products during the forecast period.

Key players have shifted their focus to commercializing home-based self-testing products in recent years, and the COVID-19 outbreak has propelled this trend. Amid government-imposed lockdowns, such products addressed clinical needs while promoting self-quarantine practices. Companies, such as Abbott, have products like BinaxNOW Card rapid test for influenza and COVID-19 that delivers results at home in 15 minutes. This product comes with a virtual guide and application to enable the testing process and display test results.

Global Rapid Tests Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 - 2033. For this report, Grand View Research has segmented the global rapid tests market report based on the product, technology, application, end use, and region.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments
  • Consumables
  • Others
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Immunoassay
  • Molecular Diagnostics
  • Other technologies
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Upper respiratory tract infections
    • Influenza and Parainfluenza virus
    • Streptococcus
    • Respiratory syncytial virus
  • Antibiotic resistant infections
  • Sepsis
    • Bacterial Sepsis
    • Fungal Sepsis
    • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics
  • Laboratories
  • At-home testing and Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Market Definitions
  • 1.2. Regional Scope
  • 1.3. Estimates And Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Type and Product Snapshot
  • 2.3. Application and End Use Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Increasing Adoption of Self-Testing & Point-of-Care Products, And Introduction of CLIA Waived Tests
      • 3.3.1.2. Growing Geriatric Population Base
      • 3.3.1.3. Introduction of Advance Technology Enablx Ed Products
      • 3.3.1.4. Growing Prevalence of Target Diseases
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Presence of Ambiguous Regulatory and Reimbursement Framework for Primary Care Setting
      • 3.3.2.2. Rapid Testing Sensitivity and Accuracy
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. Porter's Five Forces Analysis
  • 3.5. COVID-19 Impact Analysis

Chapter 4. Technology Business Analysis

  • 4.1. Rapid Tests Market: Technology Movement Analysis, 2025 & 2033
  • 4.2. Molecular Diagnostics
    • 4.2.1. Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • 4.3. Immunoassay
    • 4.3.1. Immunoassay Market, 2021 - 2033 (USD Million)
  • 4.4. Others
    • 4.4.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Product Business Analysis

  • 5.1. Rapid Tests Market: Product Movement Analysis, 2025 & 2033
  • 5.2. Instruments
    • 5.2.1. Instruments Market, 2021 - 2033 (USD Million)
  • 5.3. Consumables
    • 5.3.1. Consumables Market, 2021 - 2033 (USD Million)
  • 5.4. Others
    • 5.4.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Rapid Tests Market: Application Movement Analysis, 2025 & 2033
  • 6.2. Upper Respiratory Tract Infections
    • 6.2.1. Upper Respiratory Tract Infections Market, 2021 - 2033 (USD Million)
    • 6.2.2. Influenza And Parainfluenza Virus
      • 6.2.2.1. Influenza And Parainfluenza Virus Market, 2021 - 2033 (USD Million)
    • 6.2.3. Respiratory Syncytial Virus
      • 6.2.3.1. Respiratory Syncytial Virus Market, 2021 - 2033 (USD Million)
    • 6.2.4. Streptococcus
      • 6.2.4.1. Streptococcus Market, 2021 - 2033 (USD Million)
  • 6.3. Antibiotic-Resistant Infections (MRSA, Streptococcus Pneumonia, And Others)
    • 6.3.1. Antibiotic-Resistant Infections (MRSA, Streptococcus Pneumoniae, And Others) Market, 2021 - 2033 (USD Million)
  • 6.4. Sepsis
    • 6.4.1. Sepsis Market, 2021 - 2033 (USD Million)
    • 6.4.2. Bacterial Sepsis
      • 6.4.2.1. Bacterial Sepsis Market, 2021 - 2033 (USD Million)
    • 6.4.3. Fungal Sepsis
      • 6.4.3.1. Fungal Sepsis Market, 2021 - 2033 (USD Million)
    • 6.4.4. Others
      • 6.4.4.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. End Use Business Analysis

  • 7.1. Rapid Tests Market: End Use Movement Analysis, 2025 & 2033
  • 7.2. Hospitals & Clinics
    • 7.2.1. Hospitals & Clinics Market, 2021 - 2033 (USD Million)
  • 7.3. Laboratories
    • 7.3.1. Laboratories Market, 2021 - 2033 (USD Million)
  • 7.4. At-Home Testing And Others
    • 7.4.1. At-Home Testing And Others Market, 2021 - 2033 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Regional Market Snapshot
  • 8.2. North America
    • 8.2.1. North America Rapid Tests Market, 2021 - 2033 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.2.2.2. Key Country Dynamics
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Competitive Scenario
    • 8.2.3. Canada
      • 8.2.3.1. Canada Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.2.3.2. Key Country Dynamics
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Competitive Scenario
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.2.4.2. Key Country Dynamics
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Competitive Scenario
  • 8.3. Europe
    • 8.3.1. Europe Rapid Tests Market, 2021 - 2033 (USD Million)
    • 8.3.2. Germany
      • 8.3.2.1. Germany Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.3.2.2. Key Country Dynamics
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Competitive Scenario
    • 8.3.3. UK
      • 8.3.3.1. UK Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.3.3.2. Key Country Dynamics
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Competitive Scenario
    • 8.3.4. France
      • 8.3.4.1. France Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.3.4.2. Key Country Dynamics
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Competitive Scenario
    • 8.3.5. Italy
      • 8.3.5.1. Italy Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.3.5.2. Key Country Dynamics
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Competitive Scenario
    • 8.3.6. Spain
      • 8.3.6.1. Spain Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.3.6.2. Key Country Dynamics
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Competitive Scenario
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.3.7.2. Key Country Dynamics
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Competitive Scenario
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.3.8.2. Key Country Dynamics
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Competitive Scenario
    • 8.3.9. Norway
      • 8.3.9.1. Norway Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.3.9.2. Key Country Dynamics
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Competitive Scenario
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Rapid Tests Market, 2021 - 2033 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.4.2.2. Key Country Dynamics
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Competitive Scenario
    • 8.4.3. China
      • 8.4.3.1. China Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.4.3.2. Key Country Dynamics
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Competitive Scenario
    • 8.4.4. India
      • 8.4.4.1. India Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.4.4.2. Key Country Dynamics
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Competitive Scenario
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.4.5.2. Key Country Dynamics
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Competitive Scenario
    • 8.4.6. Australia
      • 8.4.6.1. Australia Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.4.6.2. Key Country Dynamics
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Competitive Scenario
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.4.7.2. Key Country Dynamics
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Competitive Scenario
  • 8.5. Latin America
    • 8.5.1. Latin America Rapid Tests Market, 2021 - 2033 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.5.2.2. Key Country Dynamics
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Competitive Scenario
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.5.3.2. Key Country Dynamics
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Competitive Scenario
  • 8.6. MEA
    • 8.6.1. MEA Rapid Tests Market, 2021 - 2033 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.6.2.2. Key Country Dynamics
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Competitive Scenario
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.6.3.2. Key Country Dynamics
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Competitive Scenario
    • 8.6.4. UAE
      • 8.6.4.1. UAE Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.6.4.2. Key Country Dynamics
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Competitive Scenario
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.6.5.2. Key Country Dynamics
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Competitive Scenario

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
    • 9.2.1. Acquisition
    • 9.2.2. Collaborations
    • 9.2.3. New Platform Launches
    • 9.2.4. Others
  • 9.3. Company Profiles/Listing
    • 9.3.1. BD (Becton, Dickinson and Company)
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Diasorin S.P.A
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Abbott
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Danaher Corporation
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Thermo Fisher Scientific Inc
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Biomerieux SA
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. F. Hoffmann-La Roche Ltd.
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product Benchmarking
      • 9.3.7.4. Strategic Initiatives

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 List Of Abbreviations
  • Table 3 Global Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 4 Global Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 5 Global Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 6 Global Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 7 Global Rapid Tests Market, By Region, 2021 - 2033 (USD Million)
  • Table 8 North America Rapid Tests Market, By Country, 2021 - 2033 (USD Million)
  • Table 9 North America Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 10 North America Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 11 North America Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 12 North America OTC US Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 U.S. Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 14 U.S. Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 15 U.S. Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 16 U.S. Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17 Canada Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 18 Canada Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 19 Canada Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 20 Canada Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 21 Mexico Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 22 Mexico Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 23 Mexico Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 24 Mexico Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 25 Europe Rapid Tests Market, By Country, 2021 - 2033 (USD Million)
  • Table 26 Europe Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 27 Europe Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 28 Europe Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 29 Europe Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 UK Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 31 UK Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 32 UK Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 33 UK Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 34 Germany Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 35 Germany Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 36 Germany Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 37 Germany Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38 France Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 39 France Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 40 France Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 41 France Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42 Italy Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 43 Italy Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 44 Italy Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 45 Italy Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 46 Spain Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 47 Spain Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 48 Spain Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 49 Spain Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 50 Norway Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 51 Norway Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 52 Norway Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 53 Norway Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54 Sweden Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 55 Sweden Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 56 Sweden Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 57 Sweden Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 Denmark Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 59 Denmark Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 60 Denmark Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 61 Denmark Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Rapid Tests Market, By Country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67 Japan Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 68 Japan Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 69 Japan Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 70 Japan Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 71 China Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 72 China Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 73 China Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 74 China Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 75 India Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 76 India Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 77 India Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 78 India Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79 Australia Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 80 Australia Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 81 Australia Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 82 Australia Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 83 South Korea Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 84 South Korea Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 85 South Korea Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 86 South Korea Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 87 Thailand Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 88 Thailand Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 89 Thailand Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 90 Thailand Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 91 Latin America Rapid Tests Market, By Country, 2021 - 2033 (USD Million)
  • Table 92 Latin America Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 93 Latin America Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 94 Latin America Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 95 Latin America Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 96 Brazil Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 97 Brazil Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 98 Brazil Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 99 Brazil Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 100 Argentina Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 101 Argentina Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 102 Argentina Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 103 Argentina Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 104 Middle East Africa Rapid Tests Market, By Country, 2021 - 2033 (USD Million)
  • Table 105 Middle East Africa Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 106 Middle East Africa Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 107 Middle East Africa Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 108 Middle East Africa Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 109 South Africa Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 110 South Africa Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 111 South Africa Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 112 South Africa Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 117 UAE Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 118 UAE Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 119 UAE Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 120 UAE Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 124 Kuwait Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Market Segmentation
  • Fig. 8 Market Snapshot, 2025
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Market Penetration & Growth Prospect Mapping, 2025
  • Fig. 15 Global Rapid Tests Market: Type Movement Analysis
  • Fig. 16 Instruments market, 2021 - 2033 (USD Million)
  • Fig. 17 Consumables market, 2021 - 2033 (USD Million)
  • Fig. 18 Others market, 2021 - 2033 (USD Million)
  • Fig. 19 Rapid testing technology outlook: Key takeaways
  • Fig. 20 Rapid testing market: Technology movement analysis (USD Million)
  • Fig. 21 Molecular diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 22 Immunoassay market, 2021 - 2033 (USD Million)
  • Fig. 23 Others market, 2021 - 2033 (USD Million)
  • Fig. 24 Rapid testing application outlook: Key takeaways
  • Fig. 25 Rapid testing market: Application type movement analysis (USD Million)
  • Fig. 26 Upper respiratory tract infections market, 2021 - 2033 (USD Million)
  • Fig. 27 Influenza and parainfluenza virus market, 2021 - 2033 (USD Million)
  • Fig. 28 Respiratory syncytial virus market, 2021 - 2033 (USD Million)
  • Fig. 29 Streptococcus market, 2021 - 2033 (USD Million)
  • Fig. 30 Antibiotic-resistant infections (MRSA, Streptococcus pneumonia, and others) market, 2021 - 2033 (USD Million)
  • Fig. 31 Sepsis market, 2021 - 2033 (USD Million)
  • Fig. 32 Bacterial Sepsis market, 2021 - 2033 (USD Million)
  • Fig. 33 Fungal sepsis market, 2021 - 2033 (USD Million)
  • Fig. 34 Others market, 2021 - 2033 (USD Million)
  • Fig. 35 Rapid testing End Use outlook: Key takeaways
  • Fig. 36 Rapid testing market: End Use movement analysis (USD Million)
  • Fig. 37 Hospitals & clinics market, 2021 - 2033 (USD Million)
  • Fig. 38 Laboratories market, 2021 - 2033 (USD Million)
  • Fig. 39 At-home testing and others market, 2021 - 2033 (USD Million)
  • Fig. 40 Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Regional Marketplace: Key Takeaways
  • Fig. 42 Regional Outlook, 2025 & 2033
  • Fig. 43 Global Rapid Tests Market: Regional Movement Analysis
  • Fig. 44 North America Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 US Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Canada Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Mexico Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Europe Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Germany Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 UK Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 France Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Italy Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Spain Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Denmark Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Sweden Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Norway Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Asia Pacific Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Japan Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 China Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 India Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Australia Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 South Korea Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Thailand Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Latin America Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Brazil Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Argentina Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Middle East And Africa Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 South Africa Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Saudi Arabia Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 UAE Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Kuwait Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)